PMV Pharmaceuticals Inc expected to post a loss of 45 cents a share - Earnings Preview

Pmv Pharmaceuticals

03/11/2023 18:47

* PMV Pharmaceuticals Inc  PMVP.OQ   PMVP.O  is expected
to show
no change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for PMV Pharmaceuticals
Inc
is for a loss of 45 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $12​, above​ its last closing price
of $1.91. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.46       -0.47      -0.38     Beat    20
 Mar. 31 2023  -0.44       -0.46      -0.42     Beat    8.4
 Dec. 31 2022  -0.44       -0.44      -0.43     Beat    1.9​
 Sep. 30 2022  -0.43       -0.42      -0.40     Beat    5.5
 ​​Jun.        -0.42       -0.41      -0.38     Beat    6.9
 30 2022                                                
 Mar. 31 2022  -0.43       -0.40      -0.41     Missed  -1.7​
 Dec. 31 2021  -0.35       -0.35      -0.40     Missed  -15.4
 Sep. 30 2021  -0.30       -0.30      -0.33     Missed  -9.4
 This summary was machine generated November 3 at 18:47 GMT.  All
figures in US dollars  unless otherwise stated